Aardvark Therapeutics, Inc. (AARD) Earnings
|
Expand Research on AARD
| Next EPS Date | 8/19/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/26  |
Q126 | N/A | -$0.87 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/20/26 |
Q126 | N/A | -$0.77 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/6/26 |
Q126 | N/A | -$0.80 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/23/26 | Q425 | -$0.81 | $0.00 | -$0.81 | N/A | N/A | N/A |  | | Details | |
| 11/13/25 |
Q325 | -$0.75 | -$0.77 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 8/13/25 |
Q225 | -$0.66 | -$0.70 | +$0.04 | N/A | N/A | N/A | | | Details | |
| 5/28/25 |
Q125 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
